The endocrine role of adipose tissue: Focus on adiponectin and resistin

Malaka B. Jackson, Suzette Y. Osei, Rexford S Ahima

Research output: Contribution to journalReview article

Abstract

Purpose of review: In addition to storing energy, adipose tissue secretes various proteins including leptin, adiponectin, resistin, cytokines, coagulation and vasoactive peptides. The levels of these 'adipokines' are related to adiposity; hence, they could provide molecular mechanisms for diabetes, dyslipidemia, atherosclerosis and other complications of obesity. Recent findings: Leptin inhibits feeding by binding to the long leptin receptor (LRb) in the brain, leading to activation of the JAK-STAT pathway. The leptin signal is terminated through induction of SOCS3 and FTP1B activity. The importance of these molecules has been confirmed in knockout mice. Ablation of LRb or STAT3 in neurons causes hyperphagia, obesity and neuroendoerine deficits, while the loss of SOCS3 or PTP1B prevents obesity. Adiponectin has also attracted attention because it is reduced in obesity and diabetic humans and animals. Treatment with adiponectin improves insulin sensitivity, decreases lipids by enhancing oxidation, and protects against vascular inflammation and atherosclerosis, Adiponectin is increased by thiazolidinediones and likely mediates the antidiabetics effects of these drugs. Resistin exerts an opposite effect to adiponectin by inhibiting insulin action in rodents; however, its role in humans is less certain. Summary: Identification of the key molecular pathways underlying the actions of adipocyte hormones provides new insights into their roles in health and disease. Specific targets of adipocyte hormones could potentially benefit the diagnosis and treatment of obesity and other metabolic diseases.

Original languageEnglish (US)
Pages (from-to)163-170
Number of pages8
JournalCurrent Opinion in Endocrinology and Diabetes
Volume12
Issue number2
DOIs
StatePublished - Apr 2005
Externally publishedYes

Fingerprint

Resistin
Adiponectin
Adipose Tissue
Obesity
Leptin
Adipocytes
Atherosclerosis
Hormones
Leptin Receptors
Thiazolidinediones
Hyperphagia
Adipokines
Metabolic Diseases
Adiposity
Dyslipidemias
Hypoglycemic Agents
Knockout Mice
Blood Vessels
Insulin Resistance
Rodentia

Keywords

  • Adipocyte
  • Adiponectin
  • Cytokine
  • Leptin
  • Metabolism
  • Resistin

ASJC Scopus subject areas

  • Endocrinology
  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

The endocrine role of adipose tissue : Focus on adiponectin and resistin. / Jackson, Malaka B.; Osei, Suzette Y.; Ahima, Rexford S.

In: Current Opinion in Endocrinology and Diabetes, Vol. 12, No. 2, 04.2005, p. 163-170.

Research output: Contribution to journalReview article

@article{27dc3202f3ff430287c9b38259d16301,
title = "The endocrine role of adipose tissue: Focus on adiponectin and resistin",
abstract = "Purpose of review: In addition to storing energy, adipose tissue secretes various proteins including leptin, adiponectin, resistin, cytokines, coagulation and vasoactive peptides. The levels of these 'adipokines' are related to adiposity; hence, they could provide molecular mechanisms for diabetes, dyslipidemia, atherosclerosis and other complications of obesity. Recent findings: Leptin inhibits feeding by binding to the long leptin receptor (LRb) in the brain, leading to activation of the JAK-STAT pathway. The leptin signal is terminated through induction of SOCS3 and FTP1B activity. The importance of these molecules has been confirmed in knockout mice. Ablation of LRb or STAT3 in neurons causes hyperphagia, obesity and neuroendoerine deficits, while the loss of SOCS3 or PTP1B prevents obesity. Adiponectin has also attracted attention because it is reduced in obesity and diabetic humans and animals. Treatment with adiponectin improves insulin sensitivity, decreases lipids by enhancing oxidation, and protects against vascular inflammation and atherosclerosis, Adiponectin is increased by thiazolidinediones and likely mediates the antidiabetics effects of these drugs. Resistin exerts an opposite effect to adiponectin by inhibiting insulin action in rodents; however, its role in humans is less certain. Summary: Identification of the key molecular pathways underlying the actions of adipocyte hormones provides new insights into their roles in health and disease. Specific targets of adipocyte hormones could potentially benefit the diagnosis and treatment of obesity and other metabolic diseases.",
keywords = "Adipocyte, Adiponectin, Cytokine, Leptin, Metabolism, Resistin",
author = "Jackson, {Malaka B.} and Osei, {Suzette Y.} and Ahima, {Rexford S}",
year = "2005",
month = "4",
doi = "10.1097/01.med.0000159113.87201.e8",
language = "English (US)",
volume = "12",
pages = "163--170",
journal = "Current Opinion in Endocrinology, Diabetes and Obesity",
issn = "1752-296X",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - The endocrine role of adipose tissue

T2 - Focus on adiponectin and resistin

AU - Jackson, Malaka B.

AU - Osei, Suzette Y.

AU - Ahima, Rexford S

PY - 2005/4

Y1 - 2005/4

N2 - Purpose of review: In addition to storing energy, adipose tissue secretes various proteins including leptin, adiponectin, resistin, cytokines, coagulation and vasoactive peptides. The levels of these 'adipokines' are related to adiposity; hence, they could provide molecular mechanisms for diabetes, dyslipidemia, atherosclerosis and other complications of obesity. Recent findings: Leptin inhibits feeding by binding to the long leptin receptor (LRb) in the brain, leading to activation of the JAK-STAT pathway. The leptin signal is terminated through induction of SOCS3 and FTP1B activity. The importance of these molecules has been confirmed in knockout mice. Ablation of LRb or STAT3 in neurons causes hyperphagia, obesity and neuroendoerine deficits, while the loss of SOCS3 or PTP1B prevents obesity. Adiponectin has also attracted attention because it is reduced in obesity and diabetic humans and animals. Treatment with adiponectin improves insulin sensitivity, decreases lipids by enhancing oxidation, and protects against vascular inflammation and atherosclerosis, Adiponectin is increased by thiazolidinediones and likely mediates the antidiabetics effects of these drugs. Resistin exerts an opposite effect to adiponectin by inhibiting insulin action in rodents; however, its role in humans is less certain. Summary: Identification of the key molecular pathways underlying the actions of adipocyte hormones provides new insights into their roles in health and disease. Specific targets of adipocyte hormones could potentially benefit the diagnosis and treatment of obesity and other metabolic diseases.

AB - Purpose of review: In addition to storing energy, adipose tissue secretes various proteins including leptin, adiponectin, resistin, cytokines, coagulation and vasoactive peptides. The levels of these 'adipokines' are related to adiposity; hence, they could provide molecular mechanisms for diabetes, dyslipidemia, atherosclerosis and other complications of obesity. Recent findings: Leptin inhibits feeding by binding to the long leptin receptor (LRb) in the brain, leading to activation of the JAK-STAT pathway. The leptin signal is terminated through induction of SOCS3 and FTP1B activity. The importance of these molecules has been confirmed in knockout mice. Ablation of LRb or STAT3 in neurons causes hyperphagia, obesity and neuroendoerine deficits, while the loss of SOCS3 or PTP1B prevents obesity. Adiponectin has also attracted attention because it is reduced in obesity and diabetic humans and animals. Treatment with adiponectin improves insulin sensitivity, decreases lipids by enhancing oxidation, and protects against vascular inflammation and atherosclerosis, Adiponectin is increased by thiazolidinediones and likely mediates the antidiabetics effects of these drugs. Resistin exerts an opposite effect to adiponectin by inhibiting insulin action in rodents; however, its role in humans is less certain. Summary: Identification of the key molecular pathways underlying the actions of adipocyte hormones provides new insights into their roles in health and disease. Specific targets of adipocyte hormones could potentially benefit the diagnosis and treatment of obesity and other metabolic diseases.

KW - Adipocyte

KW - Adiponectin

KW - Cytokine

KW - Leptin

KW - Metabolism

KW - Resistin

UR - http://www.scopus.com/inward/record.url?scp=17144390207&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=17144390207&partnerID=8YFLogxK

U2 - 10.1097/01.med.0000159113.87201.e8

DO - 10.1097/01.med.0000159113.87201.e8

M3 - Review article

AN - SCOPUS:17144390207

VL - 12

SP - 163

EP - 170

JO - Current Opinion in Endocrinology, Diabetes and Obesity

JF - Current Opinion in Endocrinology, Diabetes and Obesity

SN - 1752-296X

IS - 2

ER -